United Health Products Inc Quick Ratio (UEEC) starting from the second quarter 2026 to second quarter 2025, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket
 


United Health Products Inc   (UEEC)

United Health Products Inc 's Quick Ratio

UEEC's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth




Within Medical Equipment & Supplies industry United Health Products Inc booked the highest Quick Ratio than United Health Products Inc in the second quarter 2026. While total ranking remained the same in the Q2 2026 compared to the first quarter 2026 at no. .

Explain Quick Ratio?
How much Cash & cash equivalents UEEC´s has?
What are UEEC´s Current Liabilities?




UEEC Quick Ratio (Jun 30 2026)
Q2
(Mar 31 2026)
Q1
(Dec 31 2025)
Q4
(Sep 30 2025)
Q3
(Jun 30 2025)
Q2
Y / Y Current Liabilities Change 119.9 % 132.03 % 190.78 % -10.24 % -8.91 %
Y / Y Cash & cash equivalent Change - 0 % 0 % 0 % 0 %
Quick Ratio MRQ - 0 0 0 0
UEEC's Total Ranking # # # # #
Seq. Current Liabilities Change -0.07 % -12.18 % 137.85 % 5.34 % 5.44 %
Seq. Cash & cash equivalent Change - 0 % 0 % 0 % 0 %



Quick Ratio second quarter 2026 Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall Market #


Quick Ratio Statistics
High Average Low
0 0 0
 




Financial Statements
United Health Products Inc 's Current Liabilities $ 4 Millions Visit UEEC's Balance sheet
United Health Products Inc 's Cash & cash equivalent $ 0 Millions Visit UEEC's Balance sheet
Source of UEEC's Sales Visit UEEC's Sales by Geography


Cumulative United Health Products Inc 's Quick Ratio

UEEC's Quick Ratio for the trailling 12 Months

UEEC Quick Ratio

(Jun 30 2026)
12 Months
(Mar 31 2026)
12 Months
(Dec 31 2025)
12 Months
(Sep 30 2025)
12 Months
(Jun 30 2025)
12 Months
Y / Y Current Liabilities TTM Growth 99.78 % 65.61 % 31.84 % -10.97 % -6.25 %
Y / Y Cash & cash equivalent TTM Growth -25 % 0 % 0 % 0 % 0 %
Quick Ratio TTM 0 0 0 0 0
Total Ranking TTM # 4165 # 4796 # 3674 # 3732 # 3789
Seq. Current Liabilities TTM Growth 17.74 % 22.74 % 42.55 % -3.02 % -2.4 %
Seq. Cash & cash equivalent TTM Growth -25 % 0 % 0 % 0 % 0 %


On the trailing twelve months basis In Spite of the decrease in Current Liabilities in the Q2 2026 to $4.19 millions, cumulative Quick Ratio